Overview


According to FutureWise analysis, the market for Inactivated Polio And Rabies Vaccines is expected to grow with a CAGR of 5.40% over the forecast period 2024-2032, and reach a market value of US$ 1.67 Billion by 2031. 

Inactivated Polio and Rabies Vaccines are essential immunization tools in the global fight against two serious viral diseases: polio and Rabies. The Inactivated Polio Vaccine (IPV) is a crucial component of immunization programs worldwide. Comprising inactivated poliovirus strains, IPV provides immunity against all three virus types. This vaccine safeguards individuals from future poliovirus infections by prompting the immune system to produce protective antibodies. It plays a pivotal role in efforts to eradicate polio globally, particularly in regions where transmission remains a concern. Rabies vaccines are equally vital in preventing the spread of this deadly disease. Rabies vaccines are similarly crucial in halting this lethal disease's transmission. The virus is spread explicitly through the saliva of infected animals, and once symptoms become apparent, the outcome is nearly always fatal. Administered pre-emptively or in response to potential exposure, these vaccines trigger the immune system to generate antibodies designed to combat the rabies virus directly. This safeguard shields individuals who may have had contact with the virus.

The market for these vaccines holds paramount significance for public health. The success in eliminating polio from many parts of the world is primarily attributed to widespread vaccination efforts. However, the ongoing challenge lies in sustaining high vaccination coverage to prevent a resurgence.

FutureWise Market Research has published a report that provides an insightful analysis of Inactivated Polio And Rabies Vaccines Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Inactivated Polio And Rabies Vaccines Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Bharat Biotech
  • BIO-MED
  • Serum Institute of India Pvt. Ltd.
  • Kedrion Biopharma Inc.
  • GlaxoSmithKline plc.
  • Bilthoven Biologicals
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Cadila Healthcare Limited
  • Sanofi Pasteur India Pvt Ltd
  • Chiron Behring Vaccines Private Ltd
  • Zoetis Inc.
  • Elanco

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Inactivated Polio And Rabies Vaccines Market:

In April 2022, Cadila Pharmaceuticals, an Indian multinational pharmaceutical company, introduced the world's inaugural three-dose anti-rabies vaccine. This vaccine is based on a recombinant nanoparticle carrying the rabies G protein.

On the driver side, Government-led immunization programs, particularly in developing countries, increase the demand for inactivated polio and rabies vaccines. These programs aim to eradicate these diseases and protect public health. Raising awareness of the dangers posed by polio and rabies, coupled with efforts by organizations and governments to educate the public, leads to greater demand for these vaccines. Regions with higher incidences of rabies cases, often due to limited access to healthcare or the prevalence of rabies in wildlife, create a demand for rabies vaccines. Collaborative efforts between international organizations, such as the World Health Organization (WHO) and UNICEF, and governments to combat polio and rabies contribute to vaccine demand. Technological advancements in vaccine production and distribution have improved accessibility and availability, driving market growth.

However, reaching remote or underserved regions with inactivated polio and rabies vaccines can be logistically challenging, impacting distribution and coverage rates. Vaccine hesitancy, driven by misinformation or concerns about vaccine safety, can hinder vaccination efforts and decrease demand for these vaccines. The production of inactivated polio and rabies vaccines requires specialized facilities and expertise, which may be limited in certain regions, impacting supply.

By Product Type

  • Inactivated Polio Vaccine
  • Inactivated Rabies Vaccine

By Method of Inactivation

  • Radiation Method
  • Heat Inactivation
  • Solvent Detergent Method
  • pH Concentration
  • Health Activation
  • Others

By Age Group

  • Pediatrics
  • Adults

By Distribution Channel

  • Government
  • Private

By Region

  • North America
  • Europe
  •  Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the growing prevalence of Rabies and polio disease directly impacts the increased demand for the global inactivated polio and rabies vaccines market. For instance, on January 19, 2023, according to the World Health Organization, per year, around 35,172 human deaths and 21,476 human deaths occur due to Rabies in North America.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Inactivated Polio And Rabies Vaccines Market By Product Type, By Method of Inactivation, By Age Group, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Inactivated Polio And Rabies Vaccines Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Inactivated Polio And Rabies Vaccines Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Inactivated Polio And Rabies Vaccines Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Inactivated Polio And Rabies Vaccines Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Inactivated Polio Vaccine
        2. Inactivated Rabies Vaccine

  • 8.  Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Radiation Method
        2. Heat Inactivation
        3. Solvent Detergent Method
        4. pH Concentration
        5. Health Activation
        6. Others

  • 9.  Inactivated Polio And Rabies Vaccines Market, By Age Group Historical Analysis and Forecast 2024-2032 (USD Million)

    •   1. Pediatrics
        2. Adults

  • 10.  Inactivated Polio And Rabies Vaccines Market, By Distribution Channel Analysis and Forecast 2024-2032 (USD Million)

    •   1. Government
        2. Private

  • 11.  North America Inactivated Polio And Rabies Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Inactivated Polio And Rabies Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Inactivated Polio And Rabies Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Inactivated Polio And Rabies Vaccines Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Bharat Biotech
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. BIO-MED
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Serum Institute of India Pvt. Ltd.
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Kedrion Biopharma Inc.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. GlaxoSmithKline plc.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Bilthoven Biologicals
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Merck & Co., Inc.
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Pfizer Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Cadila Healthcare Limited
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Sanofi Pasteur India Pvt Ltd
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Chiron Behring Vaccines Private Ltd
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Zoetis Inc. 
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Elanco
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  Pre and Post COVID-19 Impact

    •    


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11